Compounds > simvastatin
Page last updated: 2024-08-23

simvastatin and Neurofibromatosis 1

simvastatin has been researched along with Neurofibromatosis 1 in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (33.33)29.6817
2010's3 (50.00)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Baines, RA; Dyson, A; Evans, DG; Garg, S; Ryan, M1
Catsman-Berrevoets, CE; de Wit, MC; Descheemaeker, MJ; Elgersma, Y; Legius, E; Moll, HA; Oostenbrink, R; Plasschaert, E; Renard, M; Rietman, AB; van der Vaart, T; Vergouwe, Y; Vogels, A1
Acosta, MT1
Elgersma, Y; Legius, E; Moll, HA; Plasschaert, E; Rietman, AB; van der Vaart, T1
Aarsen, FK; Arts, WF; Bouman, MJ; Catsman, CE; de Goede-Bolder, A; de Zeeuw, CI; Elgersma, Y; Krab, LC; Kushner, SA; Lequin, M; Moll, HA; Pluijm, SM; Silva, AJ; van der Geest, JN1
Jansen, JF1

Trials

3 trial(s) available for simvastatin and Neurofibromatosis 1

ArticleYear
Simvastatin for cognitive deficits and behavioural problems in patients with neurofibromatosis type 1 (NF1-SIMCODA): a randomised, placebo-controlled trial.
    The Lancet. Neurology, 2013, Volume: 12, Issue:11

    Topics: Adolescent; Child; Child Behavior Disorders; Cognition Disorders; Double-Blind Method; Drug Administration Schedule; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Neurofibromatosis 1; Placebos; Simvastatin; Time Factors; Treatment Outcome

2013
Behavioral and cognitive outcomes for clinical trials in children with neurofibromatosis type 1.
    Neurology, 2016, Jan-12, Volume: 86, Issue:2

    Topics: Adolescent; Attention; Behavior; Child; Cognition; Cognition Disorders; Female; Humans; Intelligence; Male; Neurofibromatosis 1; Neuropsychological Tests; Quality of Life; Simvastatin

2016
Effect of simvastatin on cognitive functioning in children with neurofibromatosis type 1: a randomized controlled trial.
    JAMA, 2008, Jul-16, Volume: 300, Issue:3

    Topics: Adolescent; Child; Cholesterol; Cognition; Double-Blind Method; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Magnetic Resonance Imaging; Male; Neurofibromatosis 1; Neuropsychological Tests; Simvastatin

2008

Other Studies

3 other study(ies) available for simvastatin and Neurofibromatosis 1

ArticleYear
A Targeted, Low-Throughput Compound Screen in a
    eNeuro, 2023, Volume: 10, Issue:5

    Topics: Animals; Autism Spectrum Disorder; Drosophila; Neurofibromatosis 1; Simvastatin

2023
Challenges of cognitive research in neurofibromatosis type 1.
    The Lancet. Neurology, 2013, Volume: 12, Issue:11

    Topics: Child Behavior Disorders; Cognition Disorders; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Neurofibromatosis 1; Simvastatin

2013
Statin therapy and cognitive deficits associated with neurofibromatosis type 1.
    JAMA, 2008, Nov-26, Volume: 300, Issue:20

    Topics: Animals; Child; Cognition; Disease Models, Animal; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mice; Mice, Neurologic Mutants; Neurofibromatosis 1; Simvastatin

2008